Part #7: Toward the 2024 Revision of Medical Fees

2025.10.01

Part #6: End-of-life care

2025.10.01

Part #5: Revision of Medical Fees: What was Required of Medical Institutions?

2025.10.01

Commentary: Q&A on reliability assurance when using medical information database for approval application, re-evaluation application, etc.

2025.10.01

Part #4: Drug Management and Dispensing Pharmacy

2025.10.01

Part #3: Family doctor & Priority doctor for referral consultation

2025.10.01

Part #2: Community- based Comprehensive Care System & Task-sharing

2025.10.01

Part #1: 2022 Reform of Medical Fee Structure; what you see, what you don’t

2025.10.01

Healthcare Reform in Japan; what is the impact for the pharmaceutical industry? Part2

2025.10.01

Healthcare Reform in Japan; what is the impact for the pharmaceutical industry?

2025.10.01